These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Bertolino A, Callicott JH, Elman I, Mattay VS, Tedeschi G, Frank JA, Breier A, Weinberger DR. Biol Psychiatry; 1998 May 01; 43(9):641-8. PubMed ID: 9582997 [Abstract] [Full Text] [Related]
5. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study. Blasi G, Bertolino A, Brudaglio F, Sciota D, Altamura M, Antonucci N, Scarabino T, Weinberger DR, Nardini M. Psychiatry Res; 2004 Jul 30; 131(2):95-105. PubMed ID: 15313516 [Abstract] [Full Text] [Related]
6. Decreased choline and creatine concentrations in centrum semiovale in patients with generalized anxiety disorder: relationship to IQ and early trauma. Coplan JD, Mathew SJ, Mao X, Smith EL, Hof PR, Coplan PM, Rosenblum LA, Gorman JM, Shungu DC. Psychiatry Res; 2006 Jun 30; 147(1):27-39. PubMed ID: 16797939 [Abstract] [Full Text] [Related]
7. Prognostic value of proton magnetic resonance spectroscopic imaging for surgical outcome in patients with intractable temporal lobe epilepsy and bilateral hippocampal atrophy. Li LM, Cendes F, Antel SB, Andermann F, Serles W, Dubeau F, Olivier A, Arnold DL. Ann Neurol; 2000 Feb 30; 47(2):195-200. PubMed ID: 10665490 [Abstract] [Full Text] [Related]
8. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia. O'Neill J, Levitt J, Caplan R, Asarnow R, McCracken JT, Toga AW, Alger JR. Neuroimage; 2004 Apr 30; 21(4):1781-9. PubMed ID: 15050598 [Abstract] [Full Text] [Related]
9. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging. Husted CA, Goodin DS, Hugg JW, Maudsley AA, Tsuruda JS, de Bie SH, Fein G, Matson GB, Weiner MW. Ann Neurol; 1994 Aug 30; 36(2):157-65. PubMed ID: 8053651 [Abstract] [Full Text] [Related]
10. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Bertolino A, Frye M, Callicott JH, Mattay VS, Rakow R, Shelton-Repella J, Post R, Weinberger DR. Biol Psychiatry; 2003 May 15; 53(10):906-13. PubMed ID: 12742678 [Abstract] [Full Text] [Related]
11. Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype. Callicott JH, Egan MF, Bertolino A, Mattay VS, Langheim FJ, Frank JA, Weinberger DR. Biol Psychiatry; 1998 Nov 15; 44(10):941-50. PubMed ID: 9821558 [Abstract] [Full Text] [Related]
12. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B. J Psychiatr Res; 2007 Oct 15; 41(8):625-34. PubMed ID: 16949099 [Abstract] [Full Text] [Related]
13. Hippocampal 1H MRS in first-episode bipolar I patients. Atmaca M, Yildirim H, Ozdemir H, Poyraz AK, Tezcan E, Ogur E. Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1235-9. PubMed ID: 16725248 [Abstract] [Full Text] [Related]
14. A fully automated method for tissue segmentation and CSF-correction of proton MRSI metabolites corroborates abnormal hippocampal NAA in schizophrenia. Weber-Fahr W, Ende G, Braus DF, Bachert P, Soher BJ, Henn FA, Büchel C. Neuroimage; 2002 May 30; 16(1):49-60. PubMed ID: 11969317 [Abstract] [Full Text] [Related]
15. Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine. Atmaca M, Yildirim H, Ozdemir H, Ogur E, Tezcan E. Psychol Med; 2007 Jan 30; 37(1):121-9. PubMed ID: 17094813 [Abstract] [Full Text] [Related]
16. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction. Tanaka Y, Obata T, Sassa T, Yoshitome E, Asai Y, Ikehira H, Suhara T, Okubo Y, Nishikawa T. Psychiatry Clin Neurosci; 2006 Jun 30; 60(3):365-72. PubMed ID: 16732755 [Abstract] [Full Text] [Related]
17. Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: a proton magnetic resonance spectroscopic imaging study. Bertolino A, Saunders RC, Mattay VS, Bachevalier J, Frank JA, Weinberger DR. Cereb Cortex; 1997 Dec 30; 7(8):740-8. PubMed ID: 9408038 [Abstract] [Full Text] [Related]
18. [Proton magnetic resonance spectroscopic imaging of the hippocampus in schizophrenia patients before and after surgery]. Chang HM, Qi ST, Yang KJ, Wang KW, Guo ZW, Wang H. Nan Fang Yi Ke Da Xue Xue Bao; 2009 May 30; 29(5):996-8. PubMed ID: 19460730 [Abstract] [Full Text] [Related]
19. Reproducibility of hippocampal single-Voxel proton MR spectroscopy and chemical shift imaging. Hsu YY, Chen MC, Lim KE, Chang C. AJR Am J Roentgenol; 2001 Feb 30; 176(2):529-36. PubMed ID: 11159110 [Abstract] [Full Text] [Related]
20. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas. Stadlbauer A, Moser E, Gruber S, Buslei R, Nimsky C, Fahlbusch R, Ganslandt O. Neuroimage; 2004 Oct 30; 23(2):454-61. PubMed ID: 15488395 [Abstract] [Full Text] [Related] Page: [Next] [New Search]